{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T18:58:35Z","timestamp":1716577115429},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,3,15]]},"DOI":"10.2169\/internalmedicine.5138-20","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T22:07:50Z","timestamp":1601417270000},"page":"867-872","source":"Crossref","is-referenced-by-count":7,"title":["Punctate Purpura Complicated with Immunoglobulin G4-related Disease"],"prefix":"10.2169","volume":"60","author":[{"given":"Utako","family":"Ishimoto","sequence":"first","affiliation":[{"name":"Division of Gastoroenterology and Hepatology, The Jikei University Daisan Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyoshi","family":"Kinoshita","sequence":"additional","affiliation":[{"name":"Division of Gastoroenterology and Hepatology, The Jikei University Daisan Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Koike","sequence":"additional","affiliation":[{"name":"Division of Gastoroenterology and Hepatology, The Jikei University Daisan Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Saruta","sequence":"additional","affiliation":[{"name":"Division of Gastoroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tooru","family":"Harada","sequence":"additional","affiliation":[{"name":"Division of Pathology, The Jikei University Daisan Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Stone JH, Zen Y, Deshpande V, et al. IgG4-related disease. N Engl J Med 366: 539-551, 2012.","DOI":"10.1056\/NEJMra1104650"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Kamisawa T, Zen Y, Pillai S, Stone JH, et al. IgG4-related disease. Lancet 385: 1460-1471, 2015.","DOI":"10.1016\/S0140-6736(14)60720-0"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD) 2011. Mod Rheumatol 22: 21-30, 2012.","DOI":"10.3109\/s10165-011-0571-z"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Yamada K, Hamaguchi Y, Saeki T, et al. Investigations of IgG4-related disease involving the skin. Mod Rheumatol 23: 986-993, 2013.","DOI":"10.3109\/s10165-012-0786-7"},{"key":"5","unstructured":"5. Lin W, Lu S, Chen H, et al. Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients. Rheumatology (Oxford) 54: 1982-1990, 2015."},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreastitis diagnostic criteria for autoimmune pancreatitis: guidelines of the international association of pancreastology. Pancreas 40: 352-358, 2011.","DOI":"10.1097\/MPA.0b013e3182142fd2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ohara H, Okazaki K, Tsubouchi H, et al. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. J Hepatobiliary Pancreat Sci 19: 536-542, 2012.","DOI":"10.1007\/s00534-012-0521-y"},{"key":"8","unstructured":"8. Cheuk W, Chan JK. IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity. Adv Anat Pathol 17: 303-332, 2010."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Masamune A, Kikuta K, Hamada S, et al. Nationwide epidemiclogical survey of autoimmue pancreastitis in Japan in 2016. J Gastroenterol 55: 462-470, 2020.","DOI":"10.1007\/s00535-019-01658-7"},{"key":"10","unstructured":"10. Bennett AE, Fense NA, Rodriguez-Waitkus P, Messeina JL. IgG4-related skin disease may have distinct systemic manifestations: a systematic review. Int J Dermatol 55: 1184-1195, 2016."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Takayama R, Ueno T, Saeki H, et al. Immunoglobulin G4-related disease and its skin manifestations. J Dermatol 44: 288-296, 2017.","DOI":"10.1111\/1346-8138.13723"},{"key":"12","unstructured":"12. Shenoy A, Mohandas N, Gottleb A, et al. IgG4-related disease: a review for dermotologists. Dermatol Online J 25: 13030\/gt9w91m8dz, 2019."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ise M, Yasuda F, Suzuki R, et al. Skin lesions in a patient with IgG4-related disease. Clin Exp Dermatol 39: 713-716, 2014.","DOI":"10.1111\/ced.12372"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Sato Y, Takeuchi M, Tanaka K, et al. Clinicopathologic analysis of IgG4-related skin disease. Mod Pathol 26: 523-532, 2013.","DOI":"10.1038\/modpathol.2012.196"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Tokura Y, Yagi H, Yanaguchi H, et al. IgG4-related skin disease. Br J Dermatol 171: 959-967, 2014.","DOI":"10.1111\/bjd.13296"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25: 1181-1192, 2012.","DOI":"10.1038\/modpathol.2012.72"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Khosroshahi A, Wallace ZS, Crowe JL, et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol 67: 1688-1699, 2015.","DOI":"10.1002\/art.39132"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Tsubakio K, Kiriyama K, Matsushima N, et al. Autoimmune pancreatitis successfully treated with ursodeoxycholic acid. Intern Med 41: 1142-1146, 2002.","DOI":"10.2169\/internalmedicine.41.1142"},{"key":"19","unstructured":"19. Miura H, Miyachi Y. IgG4-related retroperitoneal fibrosis and sclerosing cholangitis independent of autoimmune pancreatitis. A recurrent case after a 5-year history of spontaneous remission. JOP 10: 432-437, 2009."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kubota K, Iida H, Fujisawa T, et al. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis. Gastrointest Endosc 66: 1142-1151, 2007.","DOI":"10.1016\/j.gie.2007.06.059"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kubota K, Watanabe S, Uchiyama T, et al. Factors predictive of relapse and spontaneous remission of autoimmune pancreatitis patients treated\/not treated with corticosteroids. J Gastroenterol 46: 834-842, 2011.","DOI":"10.1007\/s00535-011-0393-y"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/6\/60_5138-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,8]],"date-time":"2023-10-08T17:15:11Z","timestamp":1696785311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/6\/60_5138-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,15]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5138-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,15]]}}}